The product formulation contains an active component that is associated with antiseptic and analgesic properties, which are relevant for the temporary relief of symptoms related to a sore throat.

Easing Acute Throat Pain and Swallowing Discomfort

This lozenge is commonly used to help with localized numbing for the acute pain and soreness arising in the pharyngeal area, which is typically a hallmark of minor throat irritations. It is relevant for easing symptoms that interfere with daily comfort, such as swallowing and speaking, contributing to improved comfort during periods of heightened symptoms.

The product is generally applied for symptoms associated with minor throat pain, irritation, and discomfort in swallowing. These uses are common across conditions characterized by episodic symptom patterns of the mouth and throat.

“The primary goal of this supportive medication is to offer symptomatic relief that helps patients cope more steadily with difficult episodes.”

---

Therapeutic Focus: Management of Acute Pharyngeal Symptoms

Strepsils Extra contributes to supportive relief for symptoms related to sore throat, minor irritation, and difficulty in swallowing that may appear suddenly during common, transient symptomatic episodes.

Who Can and Cannot Use Strepsils Extra?

This section outlines the officially documented population eligibility and non-eligibility rules for Strepsils Extra lozenges (Hexylresorcinol 2.4mg), based strictly on government regulatory labeling.

---

Eligibility and Absolute Contraindications

The medicine is officially permitted for use by adults, the elderly, and children 6 years and over. No dosage adjustment is necessary for the elderly population.

Use is absolutely contraindicated in the following groups, as stated in regulatory documents:

• Children under 6 years of age.
• Individuals with a known hypersensitivity (allergy) to the active substance, Hexylresorcinol, or to any of the other ingredients.
• Patients with specific rare hereditary metabolic problems, including fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency.

---

Restrictions and Special Considerations

Official labeling defines restricted use for certain populations:

• Pregnancy and Lactation: Use should be with caution during both pregnancy and breastfeeding due to limited human safety data.
• Diabetes: Patients with diabetes mellitus must consider that the lozenge contains both sucrose and glucose.
• Allergies: Individuals with a known wheat allergy or sensitivity to certain excipients (like Sulphur Dioxide) are advised not to take this medicine.

Interactions with other medicines and products

Official Regulatory Interaction Status

Regulatory documentation for Strepsils Extra (Hexylresorcinol 2.4 mg lozenge) confirms that no interactions are known with other medicinal products. The local action of Hexylresorcinol means that its interaction profile does not include pharmacokinetic mechanisms, such as CYP-mediated enzyme induction or inhibition, nor are any pharmacodynamic interactions documented with co-administered pharmaceuticals. No mandatory timing separation rules are required when taking this lozenge with other medications.

Interaction-Related Restrictions and Contraindications

Official restrictions are tied to interactions between the lozenge's excipients (inactive ingredients) and specific physiological conditions, rather than drug-drug interactions.

Interaction-Related Restriction	Excipient Basis
Contraindicated for individuals with fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency	Glucose and Sucrose
Contraindicated for individuals with a known wheat allergy	Wheat Starch (trace gluten)
Potential for severe hypersensitivity reactions and bronchospasm	Sulphur Dioxide (E220)

These constraints establish formal interaction restrictions specific to populations with inherited metabolic disorders or existing allergies, and are independent of any interaction with other concurrently used active medicinal ingredients.

The molecular action of the active ingredient, Hexylresorcinol, is defined by a dual-action profile targeting both peripheral sensory signaling and the structural components of surface microorganisms, with its effects strictly localized to the oropharyngeal mucosa.

---

️ Modulating Peripheral Sensory Signaling

The neurophysiological action is achieved by engaging the Voltage-Gated Sodium Channels ( Na v channels) found in the membranes of peripheral sensory nerve endings (nociceptors). Hexylresorcinol acts as a reversible blocker, physically obstructing these channels and inhibiting the influx of sodium ions ( Na^+). This molecular event stabilizes the neuronal membrane, disrupting the normal nociceptive signaling pathway and disrupting the propagation of electrical impulses along the peripheral nerves. The physiological consequence is a direct, localized modulation of afferent nerve activity.

---

️ Disruption of Surface Microbial Integrity

Concurrently, the compound affects surface microorganisms through a physicochemical disruption of the lipid bilayer and protein components of microbial cell membranes (bacteria and fungi). This interaction destabilizes the structural integrity of the microorganism, leading to the rapid leakage of essential intracellular contents. This mechanism results in a reduction in the concentration and viability of microorganisms on the mucosal surface due to membrane destabilization.

Administration Instructions: Strepsils Extra (Hexylresorcinol 2.4 mg)

The following instructions describe the administration for the Strepsils Extra Hexylresorcinol 2.4 mg oromucosal lozenge.

---

Route and Method of Administration

Strepsils Extra is intended for oral administration for a topical effect on the mucous membranes of the mouth and throat. The lozenge must be allowed to dissolve slowly in the mouth and should not be chewed or swallowed whole. This method ensures the sustained, localized release of the active ingredient.

Standard Dosing and Frequency

Population	Single Dose	Frequency	Maximum Daily Dose
Adults	One lozenge (2.4 mg)	Every 2 to 3 hours as required	12 lozenges (28.8 mg)
Older Adults	One lozenge	Every 2 to 3 hours as required	12 lozenges

Duration and Age Restrictions

Duration of Use: Use is restricted to short-term therapy only. The lozenge should not be used for more than 3 days. If symptoms worsen or fail to improve within this period, discontinuation is required.

Age Requirements: Strepsils Extra is suitable for patients 6 years of age and over. The product is not to be administered to children under 6 years due to administration constraints.

Strepsils Extra: Recent Clinical Evidence

The active ingredient in Strepsils Extra lozenges is flurbiprofen (8.75 mg), a non-steroidal anti-inflammatory drug (NSAID). Research has explored the hypothesized method of action, which is believed to involve the local inhibition of cyclooxygenase enzymes, which are responsible for the production of inflammatory mediators that cause throat pain.

Key Findings from Randomized Controlled Trials (RCTs)

Studies have examined parameters related to pain levels and difficulty swallowing in adults with sore throat due to upper respiratory tract infections. Multiple randomized, double-blind, placebo-controlled trials have been conducted using the flurbiprofen 8.75 mg lozenge.

• Onset and Duration: In one trial using the double stopwatch method, data regarding the time to the initial observed change was reported within 30 minutes of administration. Relief from sore throat pain has been observed to last for several hours after a single dose.
• Symptom Relief: A number of studies demonstrated that the flurbiprofen lozenge provided a greater reduction in self-reported sore throat pain intensity compared to placebo over a two-hour period post-dose. Significant differences were also noted in patient-reported difficulty swallowing and the sensation of a swollen throat.

Multiple-Dose and Safety Data

Research has explored the relationship between study drug administration and other outcomes, such as the need for rescue medication over a 24-hour period. Multiple-dose efficacy has been assessed over a period of up to three days, showing a sustained effect on sore throat symptoms.

Safety and tolerability have been assessed across various studies. The lozenge formulation, due to its low, localized dose, results in minimal systemic exposure compared to standard oral NSAID tablets. These studies primarily sought to collect data on observed adverse events to characterize the short-term safety profile of the 8.75 mg formulation when used as directed.

Common questions about Strepsils Extra (FAQ)

Q: How quickly should I expect Strepsils Extra to start working?

Studies on the active ingredient, Hexylresorcinol, indicate that the onset of local analgesic relief has been reported to occur within 5 minutes of administration. The medicine is designed to release its active component topically, focusing its action on the throat area.

Q: What is the main difference between Strepsils Extra and regular Strepsils?

Strepsils Extra contains Hexylresorcinol 2.4 mg, which provides a dual action by working as both a local anaesthetic (numbing agent) and an antiseptic. Other products in the Strepsils range may contain different active ingredients, such as a combination of antiseptics only, or a non-steroidal anti-inflammatory drug (NSAID) for inflammation.

Q: How long does the numbing effect of Strepsils Extra last?

Official information and studies on Hexylresorcinol indicate that the analgesic effects of the active ingredient are typically reported to last for a duration of up to 2 hours after the lozenge has been fully administered.

Q: Does Strepsils Extra have an effect on inflammation?

Regulatory documents classify the active ingredient, Hexylresorcinol, as a local anaesthetic and antiseptic. The official description of its mechanism of action does not define it as an anti-inflammatory drug, meaning its effect is primarily focused on pain relief and reducing the number of microorganisms on the surface.

Q: Does Strepsils Extra help with pain from swollen tonsils?

The product is officially indicated for the symptomatic relief of sore throat and its associated pain. The lozenge provides localized symptomatic relief within the oropharyngeal area.

Q: Does Strepsils Extra interact with alcohol?

Official regulatory product information states that no interactions are known with other medicinal products or other forms of interaction. The local action of the lozenge is a feature of its design.

Q: Can Strepsils Extra be used for a cold that causes a scratchy throat?

The product is officially indicated for the symptomatic relief of sore throat and its associated pain. A scratchy throat is considered a form of throat irritation that falls within the intended use of the product.

Q: Is Strepsils Extra safe to take with common cold remedies?

Regulatory information indicates that no interactions are known with other medicinal products. It is important that individuals are aware of all ingredients in concurrently used products, especially regarding known contraindications with the inactive ingredients in Strepsils Extra.

Q: Can Strepsils Extra cause drowsiness or affect driving?

Official regulatory information generally indicates that the product is not expected to affect the ability to drive or use machines. This statement aligns with the product's design for a local effect.

Q: Can Strepsils Extra be used for a cough that isn't related to a sore throat?

The lozenge is officially indicated for the symptomatic relief of sore throat and its associated pain. It is not indicated for the treatment of cough.

Q: Is the sugar content in Strepsils Extra significant?

Each lozenge contains approximately 1125 mg of Glucose and 1413 mg of Sucrose. This information is relevant for individuals who need to monitor their sugar intake, such as those with diabetes or specific hereditary metabolic problems.

Q: Are there any long-term effects of using Strepsils Extra repeatedly?

Official regulatory directions restrict the use of Strepsils Extra to short-term therapy only, with a maximum duration of 3 days. There is no official information available regarding the effects of using the product repeatedly over a prolonged period.

Q: Is it safe to use Strepsils Extra if I have stomach issues like acid reflux?

Strepsils Extra is designed for topical, local use in the throat. Overdosage may lead to minor gastrointestinal irritation. Official regulatory information does not list specific warnings or contraindications regarding general stomach issues like acid reflux.

Q: Does Strepsils Extra interact with hormonal birth control?

Official regulatory documents indicate that no interactions are known with other medicinal products. This statement encompasses interactions with other medications, including systemic treatments like hormonal birth control.

Q: Can Strepsils Extra cause a bitter taste in the mouth?

Taste disturbance is not listed as a documented adverse effect in the official regulatory product information. The local anaesthetic effect may temporarily alter taste perception.

Q: Is it safe to use Strepsils Extra if I have kidney or liver issues?

The product is designed to act locally in the throat with minimal systemic absorption. As a result, official regulatory information does not list specific warnings or dosage adjustments for patients with kidney (renal) or liver (hepatic) impairment.

Q: What is the role of the antiseptic component in Strepsils Extra?

The Hexylresorcinol component provides mild antiseptic activity in the throat. This is defined in regulatory documents as contributing to a reduction in the concentration and viability of microorganisms on the mucosal surface.

Q: Are there different strengths of Strepsils Extra available?

Strepsils Extra (Hexylresorcinol) is officially available in one strength, which contains 2.4 mg of the active ingredient per lozenge.

Q: What are the key findings from studies regarding the Hexylresorcinol lozenge?

Official summaries of studies on the Hexylresorcinol lozenge have reported findings on the onset of analgesic relief (within 5 minutes), the duration of the numbing effect (up to 2 hours), and the antimicrobial activity against common pathogens of the mouth and throat.

Storage and Disposal Requirements for Strepsils Extra

Official regulatory labeling dictates strict conditions for storing and disposing of Strepsils Extra lozenges to maintain their stability and ensure public safety.

---

Storage

The product must be stored at a temperature not above 25°C or 30°C, depending on the specific regulatory document for the region and presentation. To ensure protection from light and moisture, the lozenges must be kept in their original container or carton and must not be used past the expiry date printed on the packaging. All medicine must be kept out of the sight and reach of children.

---

Disposal

Expired or unused lozenges must not be disposed of via household waste or wastewater (e.g., sink or toilet). To comply with environmental and pharmaceutical waste regulations, patients are required to ask the pharmacist for the correct disposal procedure.